WatchGov

New York bills · 2025 Regular Session

New York A 265

Relates to the availability of opioid reversal agents

  1. Introduced
  2. In committee
  3. Passed House
  4. Passed Senate
  5. To Governor
  6. Became law

Sponsors

Cosponsors (15)

Summary

Official abstract published by the New York legislature

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

Text versions

Roll-call votes

State vote data last updated Oct 16, 2026, 12:24 AM.

DateVoteResultYour legislators
Jan 12, 2026
House
Assembly Vote - Vote 2passSet your home in New York to see
Jun 13, 2025
House
Assembly VotepassSet your home in New York to see

Actions